Posts tagged ‘lung cancer’

David Mu, Ph.D., takes aim at lung cancer

David Mu, Ph.D.By the time lung cancer is diagnosed, it’s often too far along to cure. Right now, lung cancer kills more Americans than any other kind of cancer. Still, David Mu, Ph.D., an associate professor of pathology in the Departments of Pathology, Biochemistry, and Molecular Biology, believes that a strong collaboration among basic scientists, clinical researchers, and treating clinicians is the key to stopping this complex disease in its tracks.

Since his arrival at Penn State College of Medicine two years ago, Mu’s laboratory work has focused on the actions of three mutated genes—TTF1, NKX2.8 and PAX9—and how they promote the development of lung tumors. In recent years, Mu, who previously worked in the biotechnology industry, linked these three genes to lung cancer.

What’s become clear since then, he says, is that mapping out the chain of events by which they are activated could help yield new drug combinations far more potent than therapies that take a more generic approach. (more…)

August 17, 2010 at 8:00 am Leave a comment


Recent Posts

Enter your email address to subscribe to Penn State Medicine and receive notifications of new posts by email.

Join 473 other followers

Share This Page

Bookmark and Share

Recent Tweets

Categories